We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
Cap. Flow
+$2.65B
Cap. Flow %
4.81%
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$255M
2
AAPL icon
Apple
AAPL
+$173M
3
MSFT icon
Microsoft
MSFT
+$166M
4
JPM icon
JPMorgan Chase
JPM
+$134M
5
AMZN icon
Amazon
AMZN
+$101M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$74.8M
2
ACN icon
Accenture
ACN
+$70.7M
3
ELV icon
Elevance Health
ELV
+$69.2M
4
HES
Hess
HES
+$59.9M
5
MSI icon
Motorola Solutions
MSI
+$53.7M

Sector Composition

Rank Sector Weight
1 Technology 34.07%
2 Financials 13.98%
3 Consumer Discretionary 10.82%
4 Communication Services 10.11%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCNCA icon
551
First Citizens BancShares
FCNCA
$24.6B
$8.88M 0.02%
4,961
+608
+14% +$1.2M
RPM icon
552
RPM International
RPM
$13.7B
$8.81M 0.02%
74,722
+6,560
+10% +$787K
SJM icon
553
J.M. Smucker
SJM
$12.6B
$8.76M 0.02%
80,684
+1,593
+2% +$173K
BAH icon
554
Booz Allen Hamilton
BAH
$8.7B
$8.71M 0.02%
87,168
+1,001
+1% +$107K
POOL icon
555
Pool Corp
POOL
$6.7B
$8.62M 0.02%
27,786
-222
-0.8% -$69.6K
NDSN icon
556
Nordson
NDSN
$16.5B
$8.58M 0.02%
37,800
-475
-1% -$105K
FDS icon
557
Factset
FDS
$9.05B
$8.54M 0.02%
29,796
+1,808
+6% +$691K
GMED icon
558
Globus Medical
GMED
$10.4B
$8.45M 0.02%
+147,589
New +$8.5M
SCCO icon
559
Southern Copper
SCCO
$141B
$8.42M 0.02%
71,280
+1,614
+2% +$158K
AKAM icon
560
Akamai
AKAM
$16.8B
$8.35M 0.02%
110,214
+1,437
+1% +$111K
JBHT icon
561
JB Hunt Transport Services
JBHT
$27.1B
$8.34M 0.02%
62,192
+2,305
+4% +$331K
DPZ icon
562
Domino's
DPZ
$11B
$8.28M 0.02%
19,178
+193
+1% +$87.6K
ATHM icon
563
Autohome
ATHM
$2.43B
$8.28M 0.02%
289,906
-4,071
-1% -$115K
MOH icon
564
Molina Healthcare
MOH
$10.3B
$8.13M 0.01%
42,491
-428
-1% -$78.8K
UDR icon
565
UDR
UDR
$12.9B
$8.11M 0.01%
217,636
+2,265
+1% +$88.3K
SOLV icon
566
Solventum
SOLV
$13.5B
$8.08M 0.01%
110,718
+7,266
+7% +$533K
RVTY icon
567
Revvity
RVTY
$12.3B
$7.87M 0.01%
89,740
+213
+0.2% +$19.3K
OTEX icon
568
Open Text
OTEX
$5.43B
$7.69M 0.01%
206,036
+16,881
+9% +$541K
DAL icon
569
Delta Air Lines
DAL
$55.9B
$7.38M 0.01%
129,990
-40,007
-24% -$2.28M
IOT icon
570
Samsara
IOT
$19.3B
$7.3M 0.01%
195,879
+12,563
+7% +$467K
ALGN icon
571
Align Technology
ALGN
$12B
$7.24M 0.01%
57,779
+3,256
+6% +$510K
CPT icon
572
Camden Property Trust
CPT
$11.3B
$7.2M 0.01%
67,388
+14,970
+29% +$1.65M
DLTR icon
573
Dollar Tree
DLTR
$23.1B
$6.99M 0.01%
74,085
+11,915
+19% +$1.28M
BIDU icon
574
Baidu
BIDU
$35.8B
$6.75M 0.01%
51,218
-910
-2% -$90.1K
NIO icon
575
NIO
NIO
$11.3B
$6.73M 0.01%
883,496

Similar funds

Aviva's Q3 2025 Portfolio in Review

As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.

  • Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
  • Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
  • Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
  • Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
  • Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
  • Aviva opened 47 new positions and closed 58 in Q3 2025.
  • Aviva's portfolio value rose 14% quarter-over-quarter to $55B.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.